Development and validation of a high-content screening in vitro micronucleus assay in CHO-k1 and HepG2 cells.

In the present study an automated image analysis assisted in vitro micronucleus assay was developed with the rodent cell line CHO-k1 and the human hepatoma cell line HepG2, which are both commonly used in regulatory genotoxicity assays. The HepG2 cell line was chosen because of the presence in these cells of a functionally active p53 protein, a functionally competent DNA-repair system, active enzymes for phase-I and -II metabolism, and an active Nrf2 electrophile responsive system. These properties may result in an assay with a high predictivity for in vivo genotoxicity. The assays with CHO-k1 and HepG2 cells were both evaluated by testing a set of compounds recommended by the European Centre for the Validation of Alternative Methods (ECVAM), among which are in vivo genotoxins and non-genotoxins. The CHO-k1 cell line showed a high sensitivity (percentage of genotoxic compounds that gave a positive result: 80%; 16/20) and specificity (percentage of non-genotoxic compounds that came out negative: 88%; 37/42). Although the sensitivity of the HepG2 cell line was lower (60%; 12/20), the specificity was high (88%; 37/42). These results were confirmed by testing an additional series of 16 genotoxic compounds. For both the CHO-k1 and the HepG2 cell line it was possible to size-classify micronuclei, enabling distinguishing aneugens from clastogens. It is concluded that two high-throughput micronucleus assays were developed that can detect genotoxic potential and allow differentiation between clastogens and aneugens. The performance scores of the CHO-k1 and HepG2 cell lines for in vivo genotoxicity were high. Application of these assays in the early discovery phase of drug development may prove to be a useful strategy to assess genotoxic potential at an early stage.

[1]  Y. Nakagawa,et al.  Cytogenetic effects of propyl gallate in CHO-K1 cells. , 2001, Mutation research.

[2]  Raffaella Corvi,et al.  Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. , 2008, Mutation research.

[3]  W. Schoonen,et al.  The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development. , 2010, Mutation research.

[4]  F. Chatani,et al.  An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  Christian Müller,et al.  Novel mammalian cell lines expressing reporter genes for the detection of environmental chemicals activating endogenous aryl hydrocarbon receptors (ArhR) or estrogen receptors (ER). , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  H. Lindberg,et al.  Characterization of chromosomes and chromosomal fragments in human lymphocyte micronuclei by telomeric and centromeric FISH. , 2008, Mutagenesis.

[7]  M. Aardema,et al.  Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. , 1999, Mutation research.

[8]  D. Pinkel,et al.  Aneuploidy detection by analysis of interphase nuclei using fluorescence in situ hybridization with chromosome-specific probes. , 1989, Progress in clinical and biological research.

[9]  A. Martelli,et al.  Induction of micronuclei and of enzyme-altered foci in the liver of female rats exposed to progesterone and three synthetic progestins. , 1998, Mutation research.

[10]  Diana Anderson,et al.  Aneugenic and clastogenic effects of doxorubicin in human lymphocytes. , 2003, Mutagenesis.

[11]  A. Martelli,et al.  Genotoxicity testing of chloramphenicol in rodent and human cells. , 1991, Mutation research.

[12]  M. Fenech.  The in vitro micronucleus technique. , 2000, Mutation research.

[13]  C Roland Wolf,et al.  Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. , 2006, Cancer research.

[14]  D. Eastmond,et al.  Kinetochore localization in micronucleated cytokinesis-blocked Chinese hamster ovary cells: a new and rapid assay for identifying aneuploidy-inducing agents. , 1989, Mutation research.

[15]  David Kirkland,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.

[16]  Y. Sato,et al.  Natural estrogens induce modulation of microtubules in Chinese hamster V79 cells in culture. , 1995, Cancer research.

[17]  T. Ishikawa,et al.  Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. , 2007, Journal of experimental therapeutics & oncology.

[18]  G. Horbach,et al.  Genotoxicity of hormonal steroids. , 2004, Toxicology letters.

[19]  A. Ribas,et al.  p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. , 1999, Cancer research.

[20]  F. Hamada,et al.  Etoposide and merbarone are clastogenic and aneugenic in the mouse bone marrow micronucleus test complemented by fluorescence in situ hybridization with the mouse minor satellite DNA probe , 2003, Environmental and molecular mutagenesis.

[21]  W. Schoonen,et al.  Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  D. Eastmond,et al.  A critical evaluation of centromeric labeling to distinguish micronuclei induced by chromosomal loss and breakage in vitro. , 1997, Mutation research.

[23]  B. Tzang,et al.  Function and sequence analyses of tumor suppressor gene p53 of CHO.K1 cells. , 1999, DNA and cell biology.

[24]  P. Carmichael,et al.  Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. , 2007, Mutation research.

[25]  R Fautz,et al.  In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results. , 2007, Mutagenesis.

[26]  J. Larner,et al.  Cloning and characterization of Chinese hamster p53 cDNA. , 1997, Gene.

[27]  C. Maier,et al.  Scoring variability of micronuclei in binucleated human lymphocytes in a case-control study. , 2006, Mutagenesis.

[28]  T Sofuni,et al.  Report from the In Vitro Micronucleus Assay Working Group. , 2003, Environmental and molecular mutagenesis.

[29]  M. Fenech,et al.  HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. , 2003, Mutation research.

[30]  V. Fessard,et al.  Aneugenic potential of okadaic acid revealed by the micronucleus assay combined with the FISH technique in CHO-K1 cells. , 2003, Mutagenesis.

[31]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.